Prospect News: News for NovaMed Inc.

E-mail us: service@prospectnews.com Or call: 212 374 2800

Bank Loans - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products

Add to balance / Manage account

Not logged in

Prospect News home > Main news index > All issuers starting with N > Issuers starting with N, CV only > All stories on NovaMed Inc. > Stories on NovaMed Inc., CV only

Search again

Enter part or all of the issuer name:

Market:

All markets No structured products Bank loans Canadian bonds CLOs Convertibles Distressed debt Emerging markets High yield Investment grade Liability management Municipals PIPEs Preferreds Private placements All leveraged markets Structured products

Market: BK = Bank loans, CV = Convertibles, DD = Distressed Debt, EM = Emerging Markets, HY = High Yield, IG = Investment Grade, LM = Liability Management, MU = Municipals, PP = PIPEs, PF = Preferreds, PV = Private Placements, SP = Structured Products
Recent items, highlighted in orange, are $4.00 each. All others are $1.00 each. Headlines in gray are not currently covered by your subscription.

NovaMed Inc.

12/30/2011	CV	Outlook 2012: Convertibles poised for modest gains after 2011's mostly negative returns
5/17/2011	CVLM	NovaMed begins tender offer for $75 million 1% convertibles due 2012
1/21/2011	CV	Market Commentary: Amgen, Micron convertibles higher dollar neutral; AMR slips; NovaMed gains on takeout
6/22/2007	CV	New Issue: NovaMed prices upsized $75 million of five-year convertibles at cheaps to yield 1%, up 15%
6/22/2007	CV	Market Commentary: Stewart flat, Dollar Financial gains slightly, NovaMed quiet on dull debuts; PrivateBancorp falls with stock
6/21/2007	CV	Market Commentary: Archstone-Smith slips on sector concerns; Dollar Financial, NovaMed, Stewart quiet in gray
6/21/2007	CV	NovaMed prices upsized $75 million convertibles to yield 1%, up 15%
6/20/2007	CV	NovaMed talks $52.5 million five-year convertibles at 0.5% to 1%, up 15% to 20%, to price Thursday
6/20/2007	CV	Market Commentary: CVRD gains early; Encysive firmer; Panda delays deal; Stewart, Dollar Financial, NovaMed plan deals
5/1/2007	CV	NovaMed files $75 million shelf registration

©2025 Prospect News. This page is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies, faxing, photocopying or any other form of reproduction.